Reexamining Remission Definitions in Rheumatoid Arthritis: Considering the Twenty-Eight-Joint Disease Activity Score, C-Reactive Protein Level, and Patient Global Assessment

Arthritis Care Res (Hoboken). 2022 Jan;74(1):1-5. doi: 10.1002/acr.24772. Epub 2021 Nov 16.

Authors

David T Felson¹, Diane Lacaille², Michael P LaValley³, Daniel Aletaha⁴

Affiliations

¹ Boston University School of Medicine, Boston, Massachusetts, and University of Manchester and the NIHR Manchester Biomedical Research Center, Manchester University NHS Trust, Manchester, UK.
² University of British Columbia and Arthritis Research Canada, Vancouver, British Colombia, Canada.
³ Boston University School of Public Health, Boston, Massachusetts.
⁴ Medical University of Vienna, Vienna, Austria.

PMID: 34783179
DOI: 10.1002/acr.24772

No abstract available

Publication types

Editorial
Research Support, N.I.H., Extramural

MeSH terms

Antirheumatic Agents / therapeutic use
Arthritis, Rheumatoid* / drug therapy
C-Reactive Protein / analysis
Humans
Patient Acuity*
Remission Induction
Severity of Illness Index*

Substances

Antirheumatic Agents
C-Reactive Protein

Grants and funding